{"id":10665,"date":"2018-10-17T16:42:13","date_gmt":"2018-10-17T14:42:13","guid":{"rendered":"http:\/\/staging.blogs.yokogawa.de\/chemical-pharma\/non-classifiee\/les-infrastructures-critiques-cest-quoi-au-juste-partie-1\/"},"modified":"2018-10-17T16:42:13","modified_gmt":"2018-10-17T14:42:13","slug":"les-infrastructures-critiques-cest-quoi-au-juste-partie-1","status":"publish","type":"post","link":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/les-infrastructures-critiques-cest-quoi-au-juste-partie-1\/","title":{"rendered":"Les infrastructures critiques : c’est quoi au juste ? (Partie 1)"},"content":{"rendered":"

Les infrastructures critiques sont des organisations ou des institutions importantes pour la communaut\u00e9 \u00e9tatique et dont la d\u00e9faillance ou la d\u00e9gradation entra\u00eenerait des p\u00e9nuries durables d’approvisionnement, de fortes perturbations de la s\u00e9curit\u00e9 publique ou d’autres cons\u00e9quences dramatiques (source\u00a0: BSI\u00a0https:\/\/www.kritis.bund.de\/SubSites\/Kritis\/DE\/Einfuehrung\/einfuehrung_node.html<\/strong><\/a>). Apr\u00e8s tout, nous d\u00e9pendons tous, sans exception, de l’\u00e9lectricit\u00e9 provenant de la prise de courant, de l’eau potable qui sort du robinet, de l’informatique et du fonctionnement du r\u00e9seau de transport \u2013 en un mot\u00a0: des lignes de vie de notre soci\u00e9t\u00e9 (source\u00a0: Schutz Kritischer Infrastrukturen \u2013 Risiko- und Krisenmanagement\u00a0; mise \u00e0 jour\u00a0: mai 2011).<\/p>\n

Toujours disponible\u00a0: syst\u00e8me de d\u00e9fense pour les infrastructures critiques<\/strong><\/h3>\n

Cependant, ces infrastructures critiques sont expos\u00e9es \u00e0 divers risques\u00a0: conditions m\u00e9t\u00e9orologiques extr\u00eames, erreurs humaines ou d\u00e9faillances techniques. Une d\u00e9faillance totale ou partielle des infrastructures critiques peut entra\u00eener des cons\u00e9quences consid\u00e9rables pour l’\u00c9tat, l’\u00e9conomie et une grande partie de la population (source\u00a0: Schutz Kritischer Infrastrukturen \u2013 Risiko- und Krisenmanagement\u00a0; mise \u00e0 jour\u00a0: mai 2011). La disponibilit\u00e9, la s\u00e9curit\u00e9 et la s\u00fbret\u00e9 des syst\u00e8mes d’information jouent un r\u00f4le extr\u00eamement essentiel et central, en particulier dans le domaine des infrastructures critiques n\u00e9cessitant une protection.<\/p>\n

Pour illustrer leur importance, jetons un coup d’\u0153il rapide sur l’organisme humain. L\u00e0 aussi, on observe une importance \u00e9l\u00e9mentaire qui consiste \u00e0 conna\u00eetre les ennemis du corps\u00a0: nous avons d\u00e9couvert les bact\u00e9ries, virus, particules de salet\u00e9, substances toxiques et poisons dans la s\u00e9rie de dessins anim\u00e9s Il \u00e9tait une fois… la vie<\/a>.<\/p>\n

Les infrastructures critiques sur la voie de la num\u00e9risation mondiale<\/strong><\/h3>\n

Dans ce dessin anim\u00e9 con\u00e7u pour les enfants, on nous a montr\u00e9 que chaque chose a son temps et est sujette au renouvellement et au changement. Et tout comme notre corps au fonctionnement fascinant \u00e9volue en permanence dans un cycle sans cesse renouvel\u00e9 afin de se transformer en quelque chose de nouveau, les infrastructures critiques sont maintenant aussi sur leur voie vers l’\u00e8re num\u00e9rique. Elle aussi doit rester comp\u00e9titive et tirer le meilleur parti du potentiel commercial qu’elle offre.
\nLes syst\u00e8mes et les installations sont de plus en plus connect\u00e9s au monde ext\u00e9rieur pour contr\u00f4ler et surveiller les processus. Cette connectivit\u00e9 agile des r\u00e9seaux a ses avantages. Les co\u00fbts sont r\u00e9duits, l’efficacit\u00e9 op\u00e9rationnelle est accrue, la sant\u00e9 des employ\u00e9s est prot\u00e9g\u00e9e et il est possible de cr\u00e9er une interop\u00e9rabilit\u00e9 entre les syst\u00e8mes existants et les nouveaux.<\/p>\n

R\u00e9silience\u00a0: une grande force int\u00e9rieure<\/strong><\/h3>\n

Revenons un instant \u00e0 l’organisme humain : il poss\u00e8de \u00e9galement des m\u00e9canismes de protection complexes pour se d\u00e9fendre contre les agents pathog\u00e8nes. La peau et les muqueuses forment la premi\u00e8re barri\u00e8re protectrice. Si des agents pathog\u00e8nes comme les bact\u00e9ries ou les virus peuvent franchir cette barri\u00e8re protectrice, diverses cellules du syst\u00e8me immunitaire entrent en jeu.<\/p>\n

Mais \u00e0 quoi ressemble la r\u00e9silience des syst\u00e8mes d’infrastructures critiques\u00a0? Disposent-elles de la base essentielle qu’est la s\u00e9curit\u00e9\u00a0? Selon le pr\u00e9sident de Bitkom, Achim Berg, l’Allemagne et l’Europe ont besoin de leurs propres comp\u00e9tences dans des domaines comme la cybers\u00e9curit\u00e9, l’intelligence artificielle, la blockchain et l’impression 3D. Nous devons conserver notre souverainet\u00e9 num\u00e9rique. La souverainet\u00e9 num\u00e9rique ne signifie pas seulement que nous utilisons les nouvelles technologies avec une ma\u00eetrise irr\u00e9prochable. Elle signifie \u00e9galement que nous pouvons les int\u00e9grer dans des syst\u00e8mes plus vastes, les s\u00e9curiser, les d\u00e9velopper et les fabriquer nous-m\u00eames dans des domaines particuli\u00e8rement critiques (source :\u00a0https:\/\/www.bitkom.org\/Presse\/Presseinformation\/Bitkom-Praesident-Achim-Berg-zur-Hightech-Strategie-2025.html<\/a>).<\/p>\n

Lisez la suite de ce billet vendredi prochain\u00a0!<\/em><\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Une infrastructure critique est une organisation ou une institution d’importance majeure pour la communaut\u00e9 publique dont la d\u00e9faillance ou la d\u00e9gradation entra\u00eenerait des p\u00e9nuries d’approvisionnement durables, des perturbations importantes de la s\u00e9curit\u00e9 publique ou d’autres cons\u00e9quences dramatiques : Apr\u00e8s tout,\u2026 <\/p>\n

Les infrastructures critiques : c’est quoi au juste ? (Partie 1)<\/span> Lire la suite\u00a0\u00bb<\/a><\/p>\n","protected":false},"author":117,"featured_media":10666,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"","footnotes":""},"categories":[2040,2038],"tags":[2091,2096,2097,2098,2093,2099,2100,376,2094],"coauthors":[],"acf":[],"yoast_head":"\nLes infrastructures critiques : c'est quoi au juste ? (Partie 1) - Chemical Pharma Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/les-infrastructures-critiques-cest-quoi-au-juste-partie-1\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Les infrastructures critiques : c'est quoi au juste ? (Partie 1)\" \/>\n<meta property=\"og:description\" content=\"Une infrastructure critique est une organisation ou une institution d'importance majeure pour la communaut\u00e9 publique dont la d\u00e9faillance ou la d\u00e9gradation entra\u00eenerait des p\u00e9nuries d'approvisionnement durables, des perturbations importantes de la s\u00e9curit\u00e9 publique ou d'autres cons\u00e9quences dramatiques : Apr\u00e8s tout,\u2026 Les infrastructures critiques : c’est quoi au juste ? (Partie 1) Lire la suite\u00a0\u00bb\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/les-infrastructures-critiques-cest-quoi-au-juste-partie-1\/\" \/>\n<meta property=\"og:site_name\" content=\"Chemical Pharma Blog\" \/>\n<meta property=\"article:published_time\" content=\"2018-10-17T14:42:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_188127382_S-1440x564_c-1024x401.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"401\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fatma Evren\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/les-infrastructures-critiques-cest-quoi-au-juste-partie-1\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/les-infrastructures-critiques-cest-quoi-au-juste-partie-1\/\"},\"author\":{\"name\":\"Fatma Evren\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/#\/schema\/person\/bef25632a9874d43e7fe7dbe212050ad\"},\"headline\":\"Les infrastructures critiques : c’est quoi au juste ? (Partie 1)\",\"datePublished\":\"2018-10-17T14:42:13+00:00\",\"dateModified\":\"2018-10-17T14:42:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/les-infrastructures-critiques-cest-quoi-au-juste-partie-1\/\"},\"wordCount\":664,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/#organization\"},\"keywords\":[\"Automatisation\",\"d'infrastructures\",\"d'infrastructures critiques\",\"institutions\",\"num\u00e9risation\",\"organisations\",\"S\u00e9curit\u00e9\",\"Services\",\"techniques\"],\"articleSection\":[\"S\u00e9curit\u00e9\",\"Services\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/les-infrastructures-critiques-cest-quoi-au-juste-partie-1\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/les-infrastructures-critiques-cest-quoi-au-juste-partie-1\/\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/les-infrastructures-critiques-cest-quoi-au-juste-partie-1\/\",\"name\":\"Les infrastructures critiques : c'est quoi au juste ? (Partie 1) - Chemical Pharma Blog\",\"isPartOf\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/#website\"},\"datePublished\":\"2018-10-17T14:42:13+00:00\",\"dateModified\":\"2018-10-17T14:42:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/les-infrastructures-critiques-cest-quoi-au-juste-partie-1\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/les-infrastructures-critiques-cest-quoi-au-juste-partie-1\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/les-infrastructures-critiques-cest-quoi-au-juste-partie-1\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Les infrastructures critiques : c’est quoi au juste ? (Partie 1)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/#website\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/\",\"name\":\"Chemical Pharma Blog\",\"description\":\"Just another blogs.yokogawa.com Sites site\",\"publisher\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/#organization\",\"name\":\"Chemical Pharma Blog\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png\",\"contentUrl\":\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png\",\"width\":302,\"height\":89,\"caption\":\"Chemical Pharma Blog\"},\"image\":{\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/#\/schema\/person\/bef25632a9874d43e7fe7dbe212050ad\",\"name\":\"Fatma Evren\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/#\/schema\/person\/image\/705d9e7d4dc124ce066ce1502b785235\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9dfa0b587fc6749dc929dd6ff1c83bf0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9dfa0b587fc6749dc929dd6ff1c83bf0?s=96&d=mm&r=g\",\"caption\":\"Fatma Evren\"},\"url\":\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/author\/fatma-evren\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Les infrastructures critiques : c'est quoi au juste ? (Partie 1) - Chemical Pharma Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/les-infrastructures-critiques-cest-quoi-au-juste-partie-1\/","og_locale":"fr_FR","og_type":"article","og_title":"Les infrastructures critiques : c'est quoi au juste ? (Partie 1)","og_description":"Une infrastructure critique est une organisation ou une institution d'importance majeure pour la communaut\u00e9 publique dont la d\u00e9faillance ou la d\u00e9gradation entra\u00eenerait des p\u00e9nuries d'approvisionnement durables, des perturbations importantes de la s\u00e9curit\u00e9 publique ou d'autres cons\u00e9quences dramatiques : Apr\u00e8s tout,\u2026 Les infrastructures critiques : c’est quoi au juste ? (Partie 1) Lire la suite\u00a0\u00bb","og_url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/les-infrastructures-critiques-cest-quoi-au-juste-partie-1\/","og_site_name":"Chemical Pharma Blog","article_published_time":"2018-10-17T14:42:13+00:00","og_image":[{"width":1024,"height":401,"url":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_188127382_S-1440x564_c-1024x401.jpg","type":"image\/jpeg"}],"author":"Fatma Evren","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/les-infrastructures-critiques-cest-quoi-au-juste-partie-1\/#article","isPartOf":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/les-infrastructures-critiques-cest-quoi-au-juste-partie-1\/"},"author":{"name":"Fatma Evren","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/#\/schema\/person\/bef25632a9874d43e7fe7dbe212050ad"},"headline":"Les infrastructures critiques : c’est quoi au juste ? (Partie 1)","datePublished":"2018-10-17T14:42:13+00:00","dateModified":"2018-10-17T14:42:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/les-infrastructures-critiques-cest-quoi-au-juste-partie-1\/"},"wordCount":664,"commentCount":0,"publisher":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/#organization"},"keywords":["Automatisation","d'infrastructures","d'infrastructures critiques","institutions","num\u00e9risation","organisations","S\u00e9curit\u00e9","Services","techniques"],"articleSection":["S\u00e9curit\u00e9","Services"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/les-infrastructures-critiques-cest-quoi-au-juste-partie-1\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/les-infrastructures-critiques-cest-quoi-au-juste-partie-1\/","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/les-infrastructures-critiques-cest-quoi-au-juste-partie-1\/","name":"Les infrastructures critiques : c'est quoi au juste ? (Partie 1) - Chemical Pharma Blog","isPartOf":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/#website"},"datePublished":"2018-10-17T14:42:13+00:00","dateModified":"2018-10-17T14:42:13+00:00","breadcrumb":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/les-infrastructures-critiques-cest-quoi-au-juste-partie-1\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/les-infrastructures-critiques-cest-quoi-au-juste-partie-1\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/les-infrastructures-critiques-cest-quoi-au-juste-partie-1\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/"},{"@type":"ListItem","position":2,"name":"Les infrastructures critiques : c’est quoi au juste ? (Partie 1)"}]},{"@type":"WebSite","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/#website","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/","name":"Chemical Pharma Blog","description":"Just another blogs.yokogawa.com Sites site","publisher":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/#organization","name":"Chemical Pharma Blog","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png","contentUrl":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png","width":302,"height":89,"caption":"Chemical Pharma Blog"},"image":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/#\/schema\/person\/bef25632a9874d43e7fe7dbe212050ad","name":"Fatma Evren","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/#\/schema\/person\/image\/705d9e7d4dc124ce066ce1502b785235","url":"https:\/\/secure.gravatar.com\/avatar\/9dfa0b587fc6749dc929dd6ff1c83bf0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9dfa0b587fc6749dc929dd6ff1c83bf0?s=96&d=mm&r=g","caption":"Fatma Evren"},"url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/author\/fatma-evren\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_188127382_S-1440x564_c.jpg",1440,564,false],"thumbnail":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_188127382_S-1440x564_c-150x150.jpg",150,150,true],"medium":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_188127382_S-1440x564_c-300x118.jpg",300,118,true],"medium_large":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_188127382_S-1440x564_c-768x301.jpg",768,301,true],"large":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_188127382_S-1440x564_c-1024x401.jpg",1024,401,true],"1536x1536":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_188127382_S-1440x564_c.jpg",1440,564,false],"2048x2048":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_188127382_S-1440x564_c.jpg",1440,564,false],"post-thumbnail":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Fotolia_188127382_S-1440x564_c-356x200.jpg",356,200,true]},"uagb_author_info":{"display_name":"Fatma Evren","author_link":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/author\/fatma-evren\/"},"uagb_comment_info":0,"uagb_excerpt":"Une infrastructure critique est une organisation ou une institution d'importance majeure pour la communaut\u00e9 publique dont la d\u00e9faillance ou la d\u00e9gradation entra\u00eenerait des p\u00e9nuries d'approvisionnement durables, des perturbations importantes de la s\u00e9curit\u00e9 publique ou d'autres cons\u00e9quences dramatiques : Apr\u00e8s tout,\u2026 Les infrastructures critiques : c’est quoi au juste ? (Partie 1) Lire la suite\u00a0\u00bb","_links":{"self":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/wp-json\/wp\/v2\/posts\/10665"}],"collection":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/wp-json\/wp\/v2\/users\/117"}],"replies":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/wp-json\/wp\/v2\/comments?post=10665"}],"version-history":[{"count":0,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/wp-json\/wp\/v2\/posts\/10665\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/wp-json\/wp\/v2\/media\/10666"}],"wp:attachment":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/wp-json\/wp\/v2\/media?parent=10665"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/wp-json\/wp\/v2\/categories?post=10665"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/wp-json\/wp\/v2\/tags?post=10665"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/fr\/wp-json\/wp\/v2\/coauthors?post=10665"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}